新型NMDAR激动剂用于治疗精神分裂症的计算建模设计
Amena Khatun Manica1, Mariam Omowunmi Daud2, Michael Olanrewaju Faloyo3
1Department of Chemistry, University of New Haven, West Haven, CT, USA. amoni4@unh.newhaven.edu.
Neurogenetics
|January 6, 2025
概括
这项研究探索了新的类似甘氨酸的化合物,通过准NMDAR甘氨酸调节部位来治疗精神分裂症. 化合物8,15和945有望提高治疗疗效和减少副作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- 精神分裂症 (SZ) 涉及积极,消极和认知症状,通常与NMDAR低功率有关.
- 目前对SZ的治疗方法有限,具有显著的副作用和可变的疗效.
- 现有的基于甘氨酸的疗法面临着高剂量副作用和有限的血脑屏障 (BBB) 透的挑战.
研究的目的:
- 识别具有增强BBB透性的新型甘氨酸类化合物,以准NMDAR甘氨酸调节部位 (GMS).
- 开发治疗精神分裂症 (SZ) 的潜在治疗药物,提高疗效和安全性.
主要方法:
- 利用ADMET分析,虚拟选和分子动力学来评估一种类似甘氨酸的化合物的库.
- 专注于旨在直接向N-甲基-D-酸盐受体 (NMDAR) GMS的化合物.
主要成果:
- 确定了Compound_8,Compound_15和Compound_945作为有前途的NMDAR激动剂.
- 这些化合物显示了改善BBB透性和GMS准的潜力.
结论:
- 这些已识别的化合物代表了精神分裂症的潜在新疗法候选者.
- 需要进一步的临床前验证,以确认这些化合物在SZ治疗中的治疗相关性.
相关概念视频
01:22Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
253
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
253
01:28Drug Therapy
23
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
23
01:28Structure-Activity Relationships and Drug Design
412
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
412
01:21Antipsychotic Drugs: Typical and Atypical Agents
120
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
120
01:14Antiepileptic Drugs: Glutamate Antagonists
239
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
239